Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation.

Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation.
复制标题

DOI:
10.3389/fimmu.2021.728082
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Zhang H
Zhang H
中科院分区:
医学2区
文献类型:
--
作者:
Peng Z;Zhang Y;Ma X;Zhou M;Wu S;Song Z;Yuan Y;Chen Y;Li Y;Wang G;Huang F;Qiao Y;Xia B;Liu W;Liu J;Zhang X;He X;Pan T;Xu H;Zhang H

文献摘要

参考文献

被引文献

相似文献

CD8+ T细胞是适应性免疫的主要组成部分,并赋予强大的保护性细胞免疫,这需要足够的T细胞数量、靶向迁移和有效的T细胞增殖。CD8+ t细胞稳态改变和增殖受损导致感染或肿瘤发生的功能失调免疫反应。然而,控制CD8+ t细胞稳态和免疫的内在因素在很大程度上仍然是难以捉摸的。在这里,我们证明了Brd4在CD8+ T细胞稳态和免疫反应中的突出作用。通过上调Myc和GLUT1的表达,Brd4促进线粒体中的葡萄糖摄取和能量产生,随后支持naïve CD8+ t细胞的存活。此外,Brd4通过维持归巢受体(CD62L和LFA-1)的表达,部分促进naïve CD8+ T细胞的运输。此外,Brd4是CD8+ T细胞对抗原刺激的反应所必需的,因为Brd4缺乏会通过减少糖酵解导致克隆扩增和终末分化的严重缺陷。重要的是,由于JQ1是一种泛brd抑制剂,严重抑制CD8+ t细胞免疫应答,因此将其用作人类免疫缺陷病毒I型(HIV-1)的抗肿瘤剂或逆转潜伏剂应更加谨慎。总的来说,我们的研究确定了Brd4在CD8+ T细胞介导的免疫监视的代谢调节中的先前意想不到的作用,并且还提供了一个潜在的免疫调节靶点。
CD8+ T cells are major components of adaptive immunity and confer robust protective cellular immunity, which requires adequate T-cell numbers, targeted migration, and efficient T-cell proliferation. Altered CD8+ T-cell homeostasis and impaired proliferation result in dysfunctional immune response to infection or tumorigenesis. However, intrinsic factors controlling CD8+ T-cell homeostasis and immunity remain largely elusive. Here, we demonstrate the prominent role of Brd4 on CD8+ T cell homeostasis and immune response. By upregulating Myc and GLUT1 expression, Brd4 facilitates glucose uptake and energy production in mitochondria, subsequently supporting naïve CD8+ T-cell survival. Besides, Brd4 promotes the trafficking of naïve CD8+ T cells partially through maintaining the expression of homing receptors (CD62L and LFA-1). Furthermore, Brd4 is required for CD8+ T cell response to antigen stimulation, as Brd4 deficiency leads to a severe defect in clonal expansion and terminal differentiation by decreasing glycolysis. Importantly, as JQ1, a pan-BRD inhibitor, severely dampens CD8+ T-cell immune response, its usage as an anti-tumor agent or latency-reversing agent for human immunodeficiency virus type I (HIV-1) should be more cautious. Collectively, our study identifies a previously-unexpected role of Brd4 in the metabolic regulation of CD8+ T cell-mediated immune surveillance and also provides a potential immunomodulation target.
DOI: 10.1016/j.celrep.2018.06.007
发表时间: 2018-07-03
期刊: Cell reports
影响因子: 8.8
作者:
Gegonne A;Chen QR;Dey A;Etzensperger R;Tai X;Singer A;Meerzaman D;Ozato K;Singer DS
通讯作者: Singer DS
DOI: 10.1038/ni.1689
发表时间: 2009-02
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.3389/fcell.2020.576654
发表时间: 2020
影响因子: 5.5
作者:
Kannan-Sundhari A;Abad C;Maloof ME;Ayad NG;Young JI;Liu XZ;Walz K
通讯作者: Walz K
DOI: 10.1016/j.cell.2015.08.012
发表时间: 2015-09-10
期刊: Cell
影响因子: 64.5
作者:
Ho PC;Bihuniak JD;Macintyre AN;Staron M;Liu X;Amezquita R;Tsui YC;Cui G;Micevic G;Perales JC;Kleinstein SH;Abel ED;Insogna KL;Feske S;Locasale JW;Bosenberg MW;Rathmell JC;Kaech SM
通讯作者: Kaech SM
DOI: 10.15252/embj.2018100293
发表时间: 2019-04-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Dey, Anup;Yang, Wenjing;Ozato, Keiko
通讯作者: Ozato, Keiko